Related Experiment Videos
Diffuse interstitial pulmonary fibrosis and lung cancer.
Acta Pathologica Japonica
|January 1, 1987
Summary
Lung cancer is more prevalent in patients with diffuse interstitial pulmonary fibrosis (DIPF). Male DIPF patients, especially those with a history of smoking, require thorough lung cancer screening.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Diffuse interstitial pulmonary fibrosis (DIPF) is a chronic lung condition.
- The relationship between DIPF and lung cancer requires further investigation.
Purpose of the Study:
- To investigate the prevalence of lung cancer in patients with DIPF.
- To identify clinicopathologic features of lung cancer in DIPF patients.
Main Methods:
- Retrospective analysis of 13,056 autopsy cases.
- Histopathologic and clinicopathologic studies of 42 cases with lung cancer and DIPF.
- Classification of DIPF into primary (Group I and II) and secondary (Group III).
Main Results:
- The prevalence of lung cancer was significantly higher in patients with primary DIPF (17%) compared to those without DIPF (7%).
- All eight lung cancer cases in primary DIPF groups were male, with 7 having a smoking history.
- Lung cancer and DIPF predominantly occurred in peripheral lung regions, often in the lower lobes; adenocarcinoma was the most common type.
Conclusions:
- Male patients with DIPF and a significant clinical history are at increased risk for developing lung cancer.
- Regular screening for lung cancer is recommended for male patients diagnosed with DIPF.